International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 5 , Pages 1598-1606 , 1 April 2008

Treatment Planning and Delivery of External Beam Radiotherapy for Pediatric Sarcoma: The St. Jude Children's Research Hospital Experience

Received 16 May 2007 ,Revised 3 December 2007 ,Accepted 6 December 2007.

References 

  1. DeLaney TF, Trofimov AV, Engelsman M, Suit HD. Advanced-technology radiation therapy in the management of bone and soft-tissue sarcoma. Cancer Control. 2005;12:27–35
  2. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. New Eng J Med. 2003;348:694–701
  3. Donaldson SS, Meza J, Breneman JC, et al. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG. Int J Radiat Oncol Biol Phys. 2001;51:718–728
  4. Spunt SL, Poquette CA, Hurt YS, et al. Prognostic factors for children and adolescents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: an analysis of 121 patients treated at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3697–3705
  5. Lee N, Akazawa C, Akazawa P, et al. A forward-planned treatment technique using multisegments in the treatment of head-and-neck cancer. Int J Radiat Biol Phys. 2004;59:584–594
  6. Xia P, Pickett B, Vigneault E, et al. Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. Int J Radiat Oncol Biol Phys. 2001;51:244–254
  7. IRB Phase II image-guided radiotherapy protocol, image guided radiotherapy for the treatment of musculoskeletal tumors: A Phase II prospective evaluation of radiation-related treatment effects, St Jude's Children's Research Hospital, principal investigator Matthew J. Krasin, M.D. Activation date: January 9, 2003.
  8. Sherouse GW, Chaney EL. The portable virtual simulator. Int J Radiat Biol Phys. 1991;21:475–482
  9. Sailer SL, Chaney EL, Rosenman JG, et al. Treatment planning at the University of North Carolina at Chapel Hill. Sem Radiat Oniol. 1992;2:267–273
  10. Zhu Y, Stovall J, Butler L, et al. Comparison of two immobilization techniques using portal film and digitally reconstructed radiographs for pediatric patients with brain tumors. Int J Radiat Biol Phys. 2000;48:1233–1240
  11. Olch AJ, Followill D, Thomadsen B, et al. In regard to Urie, et al.: current calibration treatment, and treatment planning techniques among institutions participating in the Children's Oncology Group. IJROBP 2003;55:245–260. Int J Radiat Biol Phys. 2003;56:1209–1210
  12. Wang JZ, Li XA, D'Souza WD, et al. Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT). Int J Radiat Biol Phys. 2003;57:543–552
  13. Fowler JF, Welsh JS, Howard SP. Loss of biological effect in prolonged fraction delivery. Int J Radiat Biol Phys. 2002;53:1350–1360
  14. Paganetti H. Change in tumor cell response due to prolonged dose delivery times in fractioned radiation therapy. Int J Radiat Biol Phys. 2005;63:892–900
  15. Merchant TE, Morris EB, Kun LE, et al. A prospective study of spinal cord dosimetry and neurologic outcome for infratentorial ependymoma. Int J Radiat Biol Phys. 2006;66:S111
  16. Merchant TE, Gould CJ, Xiong X, et al. Early neuron-otologic effects of three-dimensional irradiation in children with primary brain tumors. Int J Radiat Biol Phys. 2004;58:1194–1207
  17. Hua C, Bass J, Khan RB, et al. Hearing loss after radiotherapy alone for pediatric brain tumors: The effect of cochlea dose. Int J Radiat Biol Phys. 2006;66:S112
  18. Marcus KJ, Goumnerova L, Billett AL, et al. Stereotactic radiotherapy for localized low-grade gliomas in children: Final results of a prospective trial. Int J Radiat Biol Phys. 2005;61:374–379
  19. Merchent TE, Zhu Y, Thompson , et al. Preliminary results from a Phase II trial of a conformal radiation therapy for pediatric patients with localized low-grade astrocytoma and ependymoma. Int J Radiat Biol Phys. 2002;52:325–332
  20. Pediatric Brain Tumor Consortium Protocol PBTC-14, Phase I/II trial of R115777 and XRT in pediatric patients with newly diagnosed non-disseminated intrinsic diffuse brainstem gliomas, study chair Daphne Haas-Kogan, M.D. Version date: July 27, 2006.
  21. Children's Oncology Group Protocol ARST0431, Intensive multi-agent therapy, including dose-compressed cycles of Ifosfamide/Etoposide (IE) and Vincristine/Doxorubicin/Cyclophosphamide (VDC) for patients with high-risk rhabdomyosarcoma, study chair Brenda Weigel, M.D. Version date: August 3, 2006.
  22. Krasin MJ, Xiong X, Wu S, Merchant TE. The effects of external beam irradiation on the growth of flat bones in children: modeling a dose–volume effect. Int J Radiat Biol Phys. 2005;62:1458–1463
  23. Merchant TE, Nguyen L, Nguyen D, et al. Differential attenuation of clavicle growth after asymmetric mantle radiotherapy. Int J Radiat Biol Phys. 2004;59:556–561
  24. Paulino AC, Wen BC, Brown CK, et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Biol Phys. 2000;46:1239–1246
  25. Riseborough EJ, Grabias SL, Burton RI, et al. Skeletal alterations following irradiation for Wilms' tumor. J Bone Joint Surg. 1976;58:526–536
  26. Paulussen M, Ahrens S, Craft AW, et al. Ewing's tumors with primary lung metastases: survival analysis of 114 (European Intergroup) Cooperative Ewing Sarcoma Studies patients. J Clin Oncol. 1998;58:3044–3052
  27. Whelan JS, Burcombe RJ, Janinis J, et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol. 2002;13:23–30
  28. Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: A phase I–II dose escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Biol Phys. 2005;61:318–328
  29. Cassady JR. Clinical radiation nephropathy. Int J Radiat Biol Phys. 1995;31:1249–1256
  30. Carrie C, Hoffstetter S, Gomez F, et al. Impact of targeting deviations on outcome in medulloblastoma: Study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Biol Phys. 1999;57:435–439
  31. Taylor RE, Bailey CC, Robinson KJ, et al. Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Biol Phys. 2004;58:1184–1193
  32. Miralbell R, Fitzgerald TJ, Laurie F, et al. Radiotherapy in pediatric medulloblastoma: quality assessment of pediatric oncology group trial 9031. Int J Radiat Biol Phys. 2006;64:1325–1330
  33. Krasin MJ, Merchant TE, Spunt SL, et al. Early results of a prospective study delivering limited margin radiotherapy for pediatric non-rhabdo-soft tissue sarcomas (NRSTS) and aggressive fibromatoses (AF). Int J Radiat Biol Phys. 2006;66:S112
  34. Hua C, Merchant TE, Spunt SL, Krasin MJ. Early results of a prospective study delivering limited margin radiotherapy for pediatric patients with rhabdomyosarcoma. Int J Radiat Biol Phys. 2007;69:S37

 This work was supported in part by the Lance Armstrong Foundation and by the American Lebanese Syrian Associated Charities (ALSAC).

 Conflict of interest: none.

PII: S0360-3016(07)04705-0

doi: 10.1016/j.ijrobp.2007.12.013

International Journal of Radiation Oncology * Biology * Physics
Volume 70, Issue 5 , Pages 1598-1606 , 1 April 2008

Article Tools

* Image Usage & Resolution